Healthcare technology provider IMS Health Holdings announced it will merge with biopharma research contract provider Quintiles Transnational Holding in a deal valued at $9 billion. The merged company will be named Quintiles IMS Holdings, Inc. to become an industry-leading information and technology-enabled healthcare service provider. Here are ten key things to know about the $9B merger: 1.Based on equity market capitalization, the combined company is valued at more than $17.6 billion with an
Read More
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Footer
